{"nct_id":"NCT01236638","title":"Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)","status":"COMPLETED","status_verified_date":"2019-01","start_date":"2010-11","start_date_type":null,"primary_completion_date":"2014-06","primary_completion_date_type":"ACTUAL","completion_date":"2014-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}